LMAT - Is This Healthcare Stock a Buy for Dividend Growth Investors?
2023-05-17 10:07:00 ET
Provided that your portfolio is diversified to properly hedge against the risks associated with investing in stocks, it merely takes time, patience, and some well-thought-out picks to grow richer.
One stock that has worked out considerably well for its investors is LeMaitre Vascular (NASDAQ: LMAT) . A $10,000 investment in the niche medical device company made just 10 years ago would now be worth $120,000 with dividends reinvested -- nearly quadruple the S&P 500 's return over that time.
But does LeMaitre have the potential for huge, market-beating returns moving forward? Let's elaborate on the medical device company's fundamentals and valuation to make a judgment.
For further details see:
Is This Healthcare Stock a Buy for Dividend Growth Investors?